Protein and Resistance Exercise to Stop Sarcopenic Obesity Now
PRESS ON
Effects of Dietary Protein Intake and Resistance Training on Retention of Fat Free Mass During Weight Loss in Adults Over 50 With Obesity
2 other identifiers
interventional
89
1 country
1
Brief Summary
The purpose of this study is to examine the separate and combined effects of a high-protein (HP) diet and resistance training (RT) on body composition and potential biological moderators of body weight in women and men \>50y. All participants will receive dietary physical activity guidance through our group-based weight loss program, State of Slim (SOS). The SOS program will be delivered via the Zoom videoconferencing platform. These participants will be randomized to receive either a counseling-based HP diet plan or RT plan. Body composition assessments at 8 wk will identify responders and non-responders; the latter will be re-randomized to "augment" (HP: add protein supplements; RT: supervise RT) or "combine" (HP with protein supplements + supervised RT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Apr 2021
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2019
CompletedFirst Posted
Study publicly available on registry
July 10, 2019
CompletedStudy Start
First participant enrolled
April 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedResults Posted
Study results publicly available
September 22, 2026
CompletedSeptember 22, 2026
August 1, 2026
3.1 years
July 5, 2019
June 25, 2025
August 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Recruitment Rates
Rates of study recruitment will be tracked to determine clinical trial feasibility. Outcome measures are determined by the percentage of people who were originally assessed for eligibility by phone (n=469) and advanced to the next stage of recruitment.
Screening through randomization, up to 6 months.
Retention Rate (Percentage of Participants Completing Week 16 Assessment)
Retention rate is defined as the percentage of randomized participants who completed the Week 16 assessment, calculated as (number completing the Week 16 assessment divided by number randomized at baseline) x 100. In this pre-specified study outcome, retention rates are summarized by Stage 1 intervention arm.
Baseline through week 16.
Class Attendance
Average percent of scheduled group classes attended per participant from baseline to week 16, calculated as (number of sessions attended Ă· number of sessions offered) Ă— 100.
Baseline through week 16.
Stage 1 Treatment Credibility
Perceived credibility of Stage 1 interventions to produce weight loss will be measured at baseline (before responder/non-responders are identified) with the Credibility/Expectancy Questionnaire. Credibility is assessed by answering 3 questions and using a 9-point Likert scale with values ranging from 1: Not at all logical/useful/confident to 9: Very logical/useful/confident. Scores are summed across items to create a total credibility score ranging from 3 to 27, with higher scores indicating greater perceived credibility.
Baseline
Stage 2 Treatment Credibility
Perceived credibility of Stage 2 interventions to produce weight loss will be measured at Week 8 with the Credibility/Expectancy Questionnaire. Credibility is assessed by answering 3 questions and using a 9-point Likert scale with values ranging from 1: Not at all logical/useful/confident to 9: Very logical/useful/confident. Scores are summed across items to create a total credibility score ranging from 3 to 27, with higher scores indicating greater perceived credibility.
Week 8
Stage 1 Intervention Preference
Participant preferences for Stage 1 interventions will be measured at baseline by answering a 5-point Likert question with '1' and '5' representing a strong preference for either intervention and '3' representing no intervention preference. Only participants who completed the survey were analyzed.
Baseline
Stage 2 Intervention Preference
Participant preferences for Stage 2 interventions ("Intensify" versus "Combine") will be measured at week 8 by answering a 5-point Likert question with '1' and '5' representing a strong preference for either intervention and '3' representing no intervention preference. Only non-responders were asked to complete the questionnaire at this stage.
Week 8
Secondary Outcomes (9)
Body Weight: Least Squares Mean Change From Baseline to Week 16 (Stage 1 Main Effect: HP vs RT; All Participants)
Baseline to Week 16
Body Weight: Least Squares Mean Change From Baseline to Week 16 (Stage 2 Main Effect: Combine vs Intensify; Non-Responders)
Baseline to Week 16
Body Weight: Least Squares Mean Change From Baseline to Week 16 (Embedded Adaptive Interventions)
Baseline to Week 16
Fat Mass: Least Squares Mean Change From Baseline to Week 16 (Stage 1 Main Effect: HP vs RT; All Participants)
Baseline to week 16
Fat Mass: Least Squares Mean Change From Baseline to Week 16 (Stage 2 Main Effect: Combine vs Intensify; Non-Responders)
Baseline to week 16
- +4 more secondary outcomes
Study Arms (6)
High Protein Diet Counseling, Add Protein Supplement for Non-Responders (Intensify)
EXPERIMENTALEnrollment in State of Slim (SOS) weight loss program with a high protein diet. Participants identified as non-responders at the week 8 assessment will receive protein supplements to augment their intervention plan.
Resistance Training Counseling, Supervised Resistance Training for Non-Responders (Intensify)
EXPERIMENTALEnrollment in State of Slim (SOS) weight loss program with resistance training counseling sessions. Participants identified as non-responders at the week 8 assessment will receive supervised resistance exercise training sessions to augment their intervention plan.
High Protein Diet Counseling, Combine Protein and Resistance Training for Non-Responders
EXPERIMENTALEnrollment in State of Slim (SOS) weight loss program with a high protein diet. Participants identified as non-responders at the week 8 assessment will receive protein supplements and supervised resistance training sessions to augment their intervention plan.
Resistance Training Counseling, Combine Protein and Resistance Training for Non-Responders
EXPERIMENTALEnrollment in State of Slim (SOS) weight loss program with resistance training counseling sessions. Participants identified as non-responders at the week 8 assessment will receive protein supplements and supervised resistance training sessions to augment their intervention plan.
High Protein Diet Counseling, Responder
EXPERIMENTALEnrolled in the State of Slim (SOS) weight loss program with counseling to consume a high protein. Met the criteria as a responder at the week 8 assessment and did not receive any second stage augmentation strategy.
Resistance Training Counseling, Responder
EXPERIMENTALEnrolled in the State of Slim (SOS) weight loss program with counseling to engage in a full-body resistance exercise training program. Met the criteria as a responder at the week 8 assessment and did not receive any second stage augmentation strategy.
Interventions
16 week group-based weight loss program with counseling to consume a high protein diet. Approximate macronutrient distributions (carbohydrate:protein:fat) will be 32%:40%:28%.
16 week weight loss program with resistance training counseling. Participants receive counseling to follow a full-body and progressive resistance exercise training program using resistance bands that are provided by the study.
For non-responding participants initially assigned to receive high-protein dietary counseling, whey protein supplements will be provided to participants with instruction to consume the supplement twice daily. For non-responding participants initially assigned to receive resistance exercise training, participants will receive 2 days per week of small-group supervised resistance exercise training.
Non-responders from either initial randomized group assigned to this intervention receive the twice daily protein supplements and twice weekly small-group supervised resistance exercise training sessions.
Eligibility Criteria
You may qualify if:
- Male or Female
- Age ≥50 years
- Post-menopausal if Female
- BMI of 30-50 kg/m2 for ambulatory participants (less than or equal to 350 lbs.)
- BMI of 25-50 kg/m2 for wheelchair users (less than or equal to 350 lbs.)
- Ambulatory with or without a walking device or use of a manual wheelchair for mobility.
You may not qualify if:
- Untreated hyper or hypothyroidism.
- Cancer (except basal cell).
- Gastrointestinal disorders affecting food intake.
- \<3 months of stable use of medications that affect metabolism, body weight, energy expenditure or appetite.
- Current eating disorder (e.g., binge eating disorder, anorexia, or bulimia).
- Any medical condition for which following a HP diet and/or 70 minutes of exercise daily would be inadvisable.
- Uses a powered wheelchair for mobility.
- Has a pacemaker or any other life-sustaining medical implant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35294-3360, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This was a pilot Sequential Multiple Assignment Randomized Trial (SMART), and the primary outcomes relate to the feasibility of conducting a full-scale SMART (i.e., recruitment, retention, attendance, credibility, and preference). Secondary outcomes related to body weight and composition should not be considered as confirmatory as the study was not statistically powered for comparative analyses.
Results Point of Contact
- Title
- Dr. Drew Sayer
- Organization
- University of Alabama at Birmingham
Study Officials
- PRINCIPAL INVESTIGATOR
Drew Sayer, PhD
University of Alabama at Birmingham
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Investigator
Study Record Dates
First Submitted
July 5, 2019
First Posted
July 10, 2019
Study Start
April 12, 2021
Primary Completion
May 31, 2024
Study Completion
May 31, 2024
Last Updated
September 22, 2026
Results First Posted
September 22, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share